Santhera Pharmaceuticals Holding AG (SANN) — Cash Flow Quality Index
Santhera Pharmaceuticals Holding AG (SANN) has a Cash Flow Quality Index of 0.80x as of December 2023. Operating cash flow of CHF62.63 Million is below net income of CHF78.12 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Santhera Pharmaceuticals Holding AG to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Santhera Pharmaceuticals Holding AG Cash Flow Quality Index (2009–2023)
Historical Cash Flow Quality Index for Santhera Pharmaceuticals Holding AG across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Santhera Pharmaceuticals Holding AG (SANN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Santhera Pharmaceuticals Holding AG (2009–2023)
Year-by-year earnings quality comparison for Santhera Pharmaceuticals Holding AG. For live market cap and the full company financial profile, see Santhera Pharmaceuticals Holding AG stock valuation.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.86x | CHF47.27 Million | CHF54.78 Million | ▲ +111.3% |
| 2015 | -7.63x | CHF-22.39 Million | CHF2.93 Million | ▼ -853.2% |
| 2009 | -0.80x | CHF-20.75 Million | CHF25.92 Million | — |